Allianz’s Gilead Sciences GILD Stock Holding History

Allianz’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$59.9K	Sell	430 -5,040	-92%	-$706K	﹤0.01%	413
2025 Q4	$671K	Buy	5,470 +5,040	+1,172%	+$612K	0.01%	282
2025 Q3	$47.7K	Hold	430	–	–	﹤0.01%	334
2025 Q2	$47.7K	Sell	430 -62	-13%	-$6.6K	﹤0.01%	342
2025 Q1	$55.1K	Buy	492 +430	+694%	+$44.4K	﹤0.01%	355
2024 Q4	$5.71K	Sell	62 -14,025	-100%	-$1.26M	﹤0.01%	421
2024 Q3	$1.18M	Buy	14,087 +13,667	+3,254%	+$1.04M	0.03%	212
2024 Q2	$28.8K	Sell	420 -7,603	-95%	-$507K	﹤0.01%	413
2024 Q1	$588K	Buy	+8,023	New	+$617K	0.02%	254

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Allianz's GILD Position: Q1 2026 in Review

Allianz reduced its Gilead Sciences (GILD) stake by 92% in Q1 2026, selling an estimated $706K and leaving 430 shares worth $59.9K. The position accounts for ﹤0.01% of the portfolio, ranked #413.

Allianz first reported a position in GILD in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.18M in Q3 2024. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Allianz held 430 shares of Gilead Sciences worth $59.9K as of Q1 2026.
Allianz sold 5,040 Gilead Sciences shares in Q1 2026, an estimated $706K.
Gilead Sciences made up ﹤0.01% of Allianz's portfolio in Q1 2026, its #413 holding.
Allianz first reported a position in Gilead Sciences in Q1 2024 and has held it in 9 quarters since.
Allianz's Gilead Sciences position peaked at $1.18M in Q3 2024.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Allianz's 13F filing for Q1 2026, filed 11 May 2026.